SCHEMBL7143686

SCHEMBL7143686

CO/C=C(/C(=O)O)c1ccccc1C=C/C=C/c1ccc(OC)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.52
MAPT P10636 3/20 0.46
CYP2D6 P10635 2/20 0.46
MAOA P21397 2/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
RELA Q04206 2/20 0.46
BCHE P06276 1/20 0.46
CYP3A4 P08684 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
TRPA1 O75762 2/20 0.45
SNCA P37840 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7143682 1.00 MAOB (0.52) MAOBMAPTCYP2D6MAOACYP2C9
SCHEMBL7139096 0.91 MAOB (0.42) MAOBMAOACYP2C9CYP2C19TRPA1
SCHEMBL7139094 0.91 MAOB (0.42) MAOBMAOACYP2C9CYP2C19TRPA1
SCHEMBL7140080 0.88 TUBB4A (0.40) MAOBMAOATRPA1SNCAMEN1
SCHEMBL7136432 0.88 MAOB (0.46) MAOBMAPTCYP2D6MAOACYP2C9
SCHEMBL7140078 0.88 TUBB4A (0.40) MAOBMAOATRPA1SNCAMEN1
SCHEMBL7136433 0.88 MAOB (0.46) MAOBMAPTCYP2D6MAOACYP2C9
SCHEMBL7135393 0.85 TRPV1 (0.41) MAOBMAPTMEN1KMT2ANPC1
SCHEMBL7142022 0.85 AKR1C3 (0.42) MAOBMAPTRELA
SCHEMBL7135398 0.85 TRPV1 (0.41) MAOBMAPTMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996439-B1 BETA-ALKOXYACRYLATES AGAINST MALARIA HOFFMANN LA ROCHE (CH) 2003-01-08 EP disclosed
US-6084120-A ACTIVE AGAINST CHLOROQUINE-SENSITIVE PATIENTS AND AGAINST CHLOROQUINE-RESISTANT MALARIA PATHOGENS; PROPHYLAXIS AND TREATMENT; E.G., A 3 METHOXY-2-(2-(4-PHENYLBUTA-1,3-DIEN-1-YL)PHENYL)ACRYLIC ACID HOFFMANN-LA ROCHE INC. (US) 2000-07-04 US disclosed